Drugs / Clostridium Burtyricum Toa
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT05993247 | Aug 2023 → Aug 2025 | osteoarthritis | Jae Myung Park | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Clostridium Burtyricum Toa | “Probiotics combination capsule (Bacillus Subtilis 150 mg /Clostridium Burtyricum Toa 150 mg /Saccharomyces Boulardii 113 mg) per oral, three times a day, for 8 weeks” NCT05993247 ↗ |
| Route | Oral | “per oral” NCT05993247 ↗ |